文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021.

出版信息

Lancet Infect Dis. 2025 May;25(5):519-536. doi: 10.1016/S1473-3099(24)00691-1. Epub 2024 Dec 18.


DOI:10.1016/S1473-3099(24)00691-1
PMID:39708822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12018300/
Abstract

BACKGROUND: Diarrhoeal diseases claim more than 1 million lives annually and are a leading cause of death in children younger than 5 years. Comprehensive global estimates of the diarrhoeal disease burden for specific age groups of children younger than 5 years are scarce, and the burden in children older than 5 years and in adults is also understudied. We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 to assess the burden of, and trends in, diarrhoeal diseases overall and attributable to 13 pathogens, as well as the contributions of associated risk factors, in children and adults in 204 countries and territories from 1990 to 2021. METHODS: We used the Cause of Death Ensemble modelling strategy to analyse vital registration data, verbal autopsy data, mortality surveillance data, and minimally invasive tissue sampling data. We used DisMod-MR (version 2.1), a Bayesian meta-regression tool, to analyse incidence and prevalence data identified via systematic reviews, population-based surveys, and claims and inpatient data. We calculated diarrhoeal disability-adjusted life-years (DALYs) as the sum of years of life lost (YLLs) and years lived with disability (YLDs) for each location, year, and age-sex group. For aetiology estimation, we used a counterfactual approach to quantify population-attributable fractions (PAFs). Additionally, we estimated the diarrhoeal disease burden attributable to the independent effects of risk factors using the comparative risk assessment framework. FINDINGS: In 2021, diarrhoeal diseases caused an estimated 1·17 million (95% uncertainty interval 0·793-1·62) deaths globally, representing a 60·3% (50·6-69·0) decrease since 1990 (2·93 million [2·31-3·73] deaths). The most pronounced decline was in children younger than 5 years, with a 79·2% (72·4-84·6) decrease in diarrhoeal deaths. Global YLLs also decreased substantially, from 186 million (147-221) in 1990 to 51·4 million (39·9-65·9) in 2021. In 2021, an estimated 59·0 million (47·2-73·2) DALYs were attributable to diarrhoeal diseases globally, with 30·9 million (23·1-42·0) of these affecting children younger than 5 years. Leading risk factors for diarrhoeal DALYs included low birthweight and short gestation in the neonatal age groups, child growth failure in children aged between 1-5 months and 2-4 years, and unsafe water and poor sanitation in older children and adults. We estimated that the removal of all evaluated diarrhoeal risk factors would reduce global DALYs from 59·0 million (47·2-73·2) to 4·99 million (1·99-10·0) among all ages combined. Globally in 2021, rotavirus was the predominant cause of diarrhoeal deaths across all ages, with a PAF of 15·2% (11·4-20·1), followed by norovirus at 10·6% (2·3-17·0) and Cryptosporidium spp at 10·2% (7·03-14·3). In children younger than 5 years, the fatal PAF of rotavirus was 35·2% (28·7-43·0), followed by Shigella spp at 24·0% (15·2-37·9) and adenovirus at 23·8% (14·8-36·3). Other pathogens with a fatal PAF greater than 10% in children younger than 5 years included Cryptosporidium spp, typical enteropathogenicEscherichia coli, and enterotoxigenic E coli producing heat-stable toxin. INTERPRETATION: The substantial decline in the global burden of diarrhoeal diseases since 1990, particularly in children younger than 5 years, supports the effectiveness of health interventions such as oral rehydration therapy, enhanced water, sanitation, and hygiene (WASH) infrastructure, and the introduction and scale-up of rotavirus vaccination. Targeted interventions and preventive measures against key risk factors and pathogens could further reduce this burden. Continued investment in the development and distribution of vaccines for leading pathogens remains crucial. FUNDING: Bill & Melinda Gates Foundation.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/3668fcd1e8ef/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/193060dd0f6f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/a88ea3ccc418/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/5c5061ad15cd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/a2862efb65ca/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/3668fcd1e8ef/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/193060dd0f6f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/a88ea3ccc418/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/5c5061ad15cd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/a2862efb65ca/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a58/12018300/3668fcd1e8ef/gr5.jpg

相似文献

[1]
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet Infect Dis. 2025-5

[2]
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet Infect Dis. 2017-9

[3]
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[4]
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-10-17

[5]
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-8

[6]
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.

Lancet Infect Dis. 2022-11

[7]
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet. 2018-11-8

[8]
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-10-17

[9]
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Lancet Psychiatry. 2022-2

[10]
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet. 2017-9-16

引用本文的文献

[1]
The burden and etiologies of diarrhea in Asia and its countries from 1990 to 2021 and the forecast to 2040: analyses informed by the global burden of disease study 2021.

Front Public Health. 2025-8-6

[2]
The comorbidities of diarrhea and acute respiratory tract infection and risk factors among under-five children in 45 low- and middle-income countries.

Sci Rep. 2025-8-17

[3]
Childhood diarrhoeal disease in South Asian countries: a population-based analysis.

BMJ Public Health. 2025-8-10

[4]
Seroepidemiology of Human Non-Species A Rotavirus Infections in Valencia, Spain.

J Med Virol. 2025-8

[5]
The health burden of disease attributable to low calcium intake: a comprehensive analysis of trends and socioeconomic impacts from 1990 to 2021.

Front Nutr. 2025-7-9

[6]
Development and Evaluation of a Nanoparticle-Based Immunoassay for Rotavirus Detection: A Suitable Alternative to ELISA and PCR in Low-Income Setting.

Methods Protoc. 2025-7-17

[7]
-host interactions: Whats new?

Curr Res Parasitol Vector Borne Dis. 2025-6-19

[8]
Intestinal Microbiota Dysbiosis Disrupts the Mucosal Barrier, Triggering Inflammatory Responses in Gut-Kidney Interaction and Exacerbating Diarrhea.

J Inflamm Res. 2025-7-16

[9]
Paneth cells inhibit intestinal stem cell proliferation through the bone morphogenic protein 7 pathway under rotavirus-mediated intestinal injury.

World J Gastroenterol. 2025-7-14

[10]
Enteroaggregative foodborne outbreak in Shandong Province, China (2023): comprehensive epidemiology and genomic resistance profiling.

Front Microbiol. 2025-6-27

本文引用的文献

[1]
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[2]
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[3]
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[4]
Oral killed cholera vaccines for preventing cholera.

Cochrane Database Syst Rev. 2024-1-10

[5]
Beyond the Imodium, a One Health Discussion on Diarrhea and the Impact of Climate Change.

Med Sci Educ. 2023-9-5

[6]
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst's FDA approval and implications.

Gut Microbes. 2023

[7]
Prevalence of Antibiotic-Resistant spp. in Bangladesh: A Systematic Review and Meta-Analysis of 44,519 Samples.

Antibiotics (Basel). 2023-4-26

[8]
Antimicrobial-resistant Shigella: where do we go next?

Nat Rev Microbiol. 2023-7

[9]
Non-Toxin-Based Vaccination Approaches.

Pathogens. 2023-2-2

[10]
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

Lancet. 2022-2-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索